Achieve Life Sciences Inc (ACHV)
4.61
+0.04
(+0.77%)
USD |
NASDAQ |
Apr 26, 16:00
4.61
0.00 (0.00%)
After-Hours: 16:24
Achieve Life Sciences Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2020 | -0.017M |
| September 30, 2020 | -0.018M |
| June 30, 2020 | -0.015M |
| March 31, 2020 | 2.344M |
| December 31, 2019 | 5.036M |
| September 30, 2019 | 1.328M |
| June 30, 2019 | -0.062M |
| March 31, 2019 | -2.445M |
| December 31, 2018 | -5.125M |
| September 30, 2018 | -1.144M |
| June 30, 2018 | 12.62M |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | 6.31M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 2.698M |
| June 30, 2016 | -17.09M |
| March 31, 2016 | -12.26M |
| December 31, 2015 | -2.077M |
| September 30, 2015 | -18.70M |
| June 30, 2015 | -12.47M |
| March 31, 2015 | -6.457M |
| December 31, 2014 | 5.366M |
| Date | Value |
|---|---|
| September 30, 2014 | 28.67M |
| June 30, 2014 | 38.15M |
| March 31, 2014 | 36.89M |
| December 31, 2013 | 32.43M |
| September 30, 2013 | 39.47M |
| June 30, 2013 | 45.14M |
| March 31, 2013 | 8.108M |
| December 31, 2012 | -21.19M |
| September 30, 2012 | -20.20M |
| June 30, 2012 | -29.39M |
| March 31, 2012 | 19.57M |
| December 31, 2011 | 25.07M |
| September 30, 2011 | -23.45M |
| June 30, 2011 | -40.34M |
| March 31, 2011 | -72.06M |
| December 31, 2010 | -59.13M |
| September 30, 2010 | -27.92M |
| June 30, 2010 | -12.84M |
| March 31, 2010 | -2.163M |
| December 31, 2009 | 2.229M |
| September 30, 2009 | 8.636M |
| June 30, 2009 | 8.339M |
| March 31, 2009 | 3.449M |
| December 31, 2008 | 15.09M |
| September 30, 2008 | 18.78M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.062M
Minimum
Jun 2019
5.036M
Maximum
Dec 2019
1.228M
Average
-0.015M
Median
Jun 2020
Cash from Investing (TTM) Benchmarks
| Accelerate Diagnostics Inc | 8.66M |
| ENDRA Life Sciences Inc | -0.0247M |
| Perspective Therapeutics Inc | 24.37M |
| Electromed Inc | -1.219M |
| Xtant Medical Holdings Inc | -24.78M |